IKKbeta inhibitors identification part II: ligand and structure-based virtual screening.

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Drug Discovery

Background:

• IkappaB kinase (IKK) is crucial for activating the NF-kappaB complex, a key player in inflammatory and rheumatic diseases.
• Inhibiting IKKbeta offers a potential therapeutic strategy for managing inflammatory conditions.
• Existing IKKbeta inhibitors are limited, necessitating the search for novel candidates.

Purpose of the Study:

• To identify novel small molecule inhibitors of IKKbeta.
• To explore virtual screening as a method for discovering potential anti-inflammatory drug candidates.

Main Methods:

• Employed a virtual screening (VS) strategy combining pharmacophore filtering and receptor-based screening.
• Screened a database of 1.04 million compounds against IKKbeta.

Main Results:

• Identified three novel compounds demonstrating IKKbeta inhibitory activity in the micromolar range.
• The identified compounds represent potential starting points for developing new anti-inflammatory therapeutics.

Conclusions:

• Virtual screening is an effective method for identifying novel IKKbeta inhibitors.
• The discovered compounds hold promise as future anti-inflammatory drug candidates pending optimization and clinical trials.